The effect of deactivation or silencing of tumor stroma with angiogenesis inhibitor on malignancy of tumor metastases
Background: Neuroblastoma (NB) is a pediatric tumor in infants and young children. The survival rate is only around 50 percent for high-risk NB despite advanced and intense multi-modal therapy. Current research aims to find new effective treatment additional to modern therapy to improve prognosis of...
Main Author: | |
---|---|
Format: | Others |
Language: | English |
Published: |
Uppsala universitet, Institutionen för farmaceutisk biovetenskap
2021
|
Subjects: | |
Online Access: | http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-445622 |